contextflow pricing
No price or unit of charge is published; sales start from a demo. contextflow licenses ADVANCE Chest CT under published general terms (AGBs, in German) with electronic delivery, a one week acceptance test and the statutory warranty period, and resells partner products (RevealAI-Lung, CINA-iPE). The fee and its basis (per study, per site or per year), whether modules can be bought separately, and whether pricing changed after the June 2026 acquisition by 4DMedical are not published.
How contextflow pricing works
- Pricing model
- Not published; software license under published general terms
- Implementation
- Not disclosed. No implementation, integration or onboarding fee is published, and no deployment timeline. The likely shape of the work can be inferred only loosely, since the stated integration approach delivers findings inside the radiologist's existing native viewer, which usually requires vendor specific integration work with the viewer or archiving system in use at each site, and no viewer or archiving vendor is named. Whether the reference case corpus is deployed locally or accessed remotely would also affect installation materially, and neither is described. Nothing states whether the vendor performs integration work, charges for it, or scopes it per site.
- Business associate agreement
- Not disclosed. contextflow publishes no data protection position of any kind. The applicable regime is European rather than United States, since certification and deployment are European and the company describes no United States presence, which relocates the omission rather than excusing it: European hospitals require a data processing agreement, a documented lawful basis and a transfer position before patient imaging moves, and none is published. The product architecture raises a sharper question than the missing template. Reference case retrieval depends on a corpus of other patients' imaging being held and searchable at read time, so a radiologist using this product is shown another patient's chest scan. Where that corpus came from, under what consent, whether it remains identifiable, and whether customer studies are added to it are all unaddressed. Acquisition by a company listed outside Europe adds a cross border transfer question that did not previously arise, and what the acquisition changes for European customers is not stated.
contextflow pricing against its alternatives
Published prices for contextflow and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- CcontextflowNo published price
- RRiverain TechnologiesNo published price
- BBehold.aiNot published. Now sold by a successor entity
- QQure AINo published price
- RRayscapeNot published (free AWS Marketplace subscription listed)
- OOptellumNo published price
- IInfervisionNo published price
- BBrainomixNo published price
- AAzra AINo pricing published. Sold through an enterprise review
contextflow pricing, answered
How much does contextflow cost?
contextflow does not publish a price. The fee and its basis (per study, per site or per year), whether modules can be bought separately, and whether pricing changed after the June 2026 acquisition by 4DMedical are not published.
Does contextflow charge an implementation fee?
Not disclosed. No implementation, integration or onboarding fee is published, and no deployment timeline. The likely shape of the work can be inferred only loosely, since the stated integration approach delivers findings inside the radiologist's existing native viewer, which usually requires vendor specific integration work with the viewer or archiving system in use at each site, and no viewer or archiving vendor is named. Whether the reference case corpus is deployed locally or accessed remotely would also affect installation materially, and neither is described. Nothing states whether the vendor performs integration work, charges for it, or scopes it per site.
Does contextflow offer a business associate agreement?
Not disclosed. contextflow publishes no data protection position of any kind. The applicable regime is European rather than United States, since certification and deployment are European and the company describes no United States presence, which relocates the omission rather than excusing it: European hospitals require a data processing agreement, a documented lawful basis and a transfer position before patient imaging moves, and none is published. The product architecture raises a sharper question than the missing template. Reference case retrieval depends on a corpus of other patients' imaging being held and searchable at read time, so a radiologist using this product is shown another patient's chest scan. Where that corpus came from, under what consent, whether it remains identifiable, and whether customer studies are added to it are all unaddressed. Acquisition by a company listed outside Europe adds a cross border transfer question that did not previously arise, and what the acquisition changes for European customers is not stated.